Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Cell Rep ; 31(8): 107675, 2020 05 26.
Artículo en Inglés | MEDLINE | ID: mdl-32460026

RESUMEN

Genome stability requires coordination of DNA replication origin activation and replication fork progression. RTEL1 is a regulator of homologous recombination (HR) implicated in meiotic cross-over control and DNA repair in C. elegans. Through a genome-wide synthetic lethal screen, we uncovered an essential genetic interaction between RTEL1 and DNA polymerase (Pol) epsilon. Loss of POLE4, an accessory subunit of Pol epsilon, has no overt phenotype in worms. In contrast, the combined loss of POLE-4 and RTEL-1 results in embryonic lethality, accumulation of HR intermediates, genome instability, and cessation of DNA replication. Similarly, loss of Rtel1 in Pole4-/- mouse cells inhibits cellular proliferation, which is associated with persistent HR intermediates and incomplete DNA replication. We propose that RTEL1 facilitates genome-wide fork progression through its ability to metabolize DNA secondary structures that form during DNA replication. Loss of this function becomes incompatible with cell survival under conditions of reduced origin activation, such as Pol epsilon hypomorphy.


Asunto(s)
ADN Helicasas/genética , ADN Polimerasa II/genética , Replicación del ADN/genética , Inestabilidad Genómica/genética , Animales , Humanos
2.
Mol Cell ; 70(4): 707-721.e7, 2018 05 17.
Artículo en Inglés | MEDLINE | ID: mdl-29754823

RESUMEN

DNA polymerase ε (POLE) is a four-subunit complex and the major leading strand polymerase in eukaryotes. Budding yeast orthologs of POLE3 and POLE4 promote Polε processivity in vitro but are dispensable for viability in vivo. Here, we report that POLE4 deficiency in mice destabilizes the entire Polε complex, leading to embryonic lethality in inbred strains and extensive developmental abnormalities, leukopenia, and tumor predisposition in outbred strains. Comparable phenotypes of growth retardation and immunodeficiency are also observed in human patients harboring destabilizing mutations in POLE1. In both Pole4-/- mouse and POLE1 mutant human cells, Polε hypomorphy is associated with replication stress and p53 activation, which we attribute to inefficient replication origin firing. Strikingly, removing p53 is sufficient to rescue embryonic lethality and all developmental abnormalities in Pole4 null mice. However, Pole4-/-p53+/- mice exhibit accelerated tumorigenesis, revealing an important role for controlled CMG and origin activation in normal development and tumor prevention.


Asunto(s)
Carcinogénesis/patología , ADN Polimerasa II/química , ADN Polimerasa II/fisiología , Replicación del ADN , Discapacidades del Desarrollo/etiología , Trastornos del Crecimiento/etiología , Leucopenia/etiología , Animales , Carcinogénesis/genética , Células Cultivadas , Embrión de Mamíferos/metabolismo , Embrión de Mamíferos/patología , Femenino , Humanos , Recién Nacido , Masculino , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Mutación , Proteína p53 Supresora de Tumor/fisiología
3.
DNA Repair (Amst) ; 19: 152-62, 2014 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-24815912

RESUMEN

DNA secondary structures are largely advantageous for numerous cellular processes but can pose specific threats to the progression of the replication machinery and therefore genome duplication and cell division. A number of specialized enzymes dismantle these structures to allow replication fork progression to proceed faithfully. In this review, we discuss the in vitro and in vivo data that has lead to the identification of these enzymes in eukaryotes, and the evidence that suggests that they act specifically at replication forks to resolve secondary structures. We focus on the role of helicases, which catalyze the dissociation of nucleotide complexes, and on the role of nucleases, which cleave secondary structures to allow replication fork progression at the expense of local rearrangements. Finally, we discuss outstanding questions in terms of dismantling DNA secondary structures, as well as the interplay between diverse enzymes that act upon specific types of structures.


Asunto(s)
Reparación del ADN/genética , Replicación del ADN/genética , Eucariontes/genética , Telómero/genética , Daño del ADN/genética , ADN Helicasas/genética , Desoxirribonucleasas/genética , Desoxirribonucleasas/metabolismo , G-Cuádruplex , Humanos , Secuencias Invertidas Repetidas , Conformación de Ácido Nucleico , Repeticiones de Trinucleótidos/genética
4.
Genes Dev ; 24(6): 521-36, 2010 Mar 15.
Artículo en Inglés | MEDLINE | ID: mdl-20203129

RESUMEN

Chromosomal double-strand breaks (DSBs) are considered to be among the most deleterious DNA lesions found in eukaryotic cells due to their propensity to promote genome instability. DSBs occur as a result of exogenous or endogenous DNA damage, and also occur during meiotic recombination. DSBs are often repaired through a process called homologous recombination (HR), which employs the sister chromatid in mitotic cells or the homologous chromosome in meiotic cells, as a template for repair. HR frequently involves the formation and resolution of four-way DNA structures referred to as the Holliday junction (HJ). Despite extensive study, the machinery and mechanisms used to process these structures in eukaryotes have remained poorly understood. Recent work has identified XPG and UvrC/GIY domain-containing structure-specific endonucleases that can symmetrically cleave HJs in vitro in a manner that allows for religation without additional processing, properties that are reminiscent of the classical RuvC HJ resolvase in bacteria. Genetic studies reveal potential roles for these HJ resolvases in repair after DNA damage and during meiosis. The stage is now set for a more comprehensive understanding of the specific roles these enzymes play in the response of cells to DSBs, collapsed replication forks, telomere dysfunction, and meiotic recombination.


Asunto(s)
Reparación del ADN/fisiología , ADN Cruciforme/metabolismo , Resolvasas de Unión Holliday/metabolismo , Recombinasas/metabolismo , Animales , Roturas del ADN de Doble Cadena , ADN Cruciforme/genética , Endodesoxirribonucleasas/metabolismo , Eucariontes/enzimología , Humanos , Proteínas Nucleares/metabolismo
5.
J Med Chem ; 52(24): 8047-56, 2009 Dec 24.
Artículo en Inglés | MEDLINE | ID: mdl-19929003

RESUMEN

Inhibition of methionine aminopeptidase-2 (MetAP2) represents a novel approach to antiangiogenic therapy. We describe the synthesis and activity of fumagillin analogues that address the pharmacokinetic and safety liabilities of earlier candidates in this compound class. Two-step elaboration of fumagillol with amines yielded a diverse series of carbamates at C6 of the cyclohexane spiroepoxide. The most potent of these compounds exhibited subnanomolar inhibition of cell proliferation in HUVEC and BAEC assays. Although a range of functionalities were tolerated at this position, alpha-trisubstituted amines possessed markedly decreased inhibitory activity, and this could be rationalized by modeling based on the known fumagillin-MetAP2 crystal structure. The lead compound resulting from these studies, (3R,4S,5S,6R)-5-methoxy-4-((2R,3R)-2-methyl-3-(3-methylbut-2-enyl)oxiran-2-yl)-1-oxaspiro[2.5]octan-6-yl (R)-1-amino-3-methyl-1-oxobutan-2-ylcarbamate, (PPI-2458), demonstrated an improved pharmacokinetic profile relative to the earlier clinical candidate TNP-470, and has advanced into phase I clinical studies in non-Hodgkin's lymphoma and solid cancers.


Asunto(s)
Aminopeptidasas/antagonistas & inhibidores , Carbamatos/química , Carbamatos/farmacología , Ciclohexanos/química , Ciclohexanos/farmacología , Ácidos Grasos Insaturados/química , Ácidos Grasos Insaturados/farmacología , Metaloendopeptidasas/antagonistas & inhibidores , Aminoácidos/química , Animales , Bovinos , Procesos de Crecimiento Celular/efectos de los fármacos , Células Endoteliales/citología , Células Endoteliales/efectos de los fármacos , Humanos , Modelos Moleculares , Sesquiterpenos/química , Sesquiterpenos/farmacología , Relación Estructura-Actividad
6.
Nat Chem Biol ; 5(9): 647-54, 2009 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-19648931

RESUMEN

Biochemical combinatorial techniques such as phage display, RNA display and oligonucleotide aptamers have proven to be reliable methods for generation of ligands to protein targets. Adapting these techniques to small synthetic molecules has been a long-sought goal. We report the synthesis and interrogation of an 800-million-member DNA-encoded library in which small molecules are covalently attached to an encoding oligonucleotide. The library was assembled by a combination of chemical and enzymatic synthesis, and interrogated by affinity selection. We describe methods for the selection and deconvolution of the chemical display library, and the discovery of inhibitors for two enzymes: Aurora A kinase and p38 MAP kinase.


Asunto(s)
ADN/química , Diseño de Fármacos , Inhibidores de Proteínas Quinasas/síntesis química , Bibliotecas de Moléculas Pequeñas/síntesis química , Animales , Aurora Quinasas , Técnicas Químicas Combinatorias , ADN/genética , Modelos Moleculares , Inhibidores de Proteínas Quinasas/química , Inhibidores de Proteínas Quinasas/farmacología , Proteínas Serina-Treonina Quinasas/antagonistas & inhibidores , Bibliotecas de Moléculas Pequeñas/química , Bibliotecas de Moléculas Pequeñas/farmacología , Proteínas Quinasas p38 Activadas por Mitógenos/antagonistas & inhibidores
7.
Bioorg Med Chem Lett ; 19(17): 5128-31, 2009 Sep 01.
Artículo en Inglés | MEDLINE | ID: mdl-19648008

RESUMEN

Fumagillin, an irreversible inhibitor of MetAP2, has been shown to potently inhibit growth of malaria parasites in vitro. Here, we demonstrate activity of fumagillin analogs with an improved pharmacokinetic profile against malaria parasites, trypanosomes, and amoebas. A subset of the compounds showed efficacy in a murine malaria model. The observed SAR forms a basis for further optimization of fumagillin based inhibitors against parasitic targets by inhibition of MetAP2.


Asunto(s)
Aminopeptidasas/antagonistas & inhibidores , Antimaláricos/química , Ciclohexanos/química , Ácidos Grasos Insaturados/química , Metaloendopeptidasas/antagonistas & inhibidores , Administración Oral , Aminopeptidasas/metabolismo , Animales , Antimaláricos/síntesis química , Antimaláricos/farmacología , Ciclohexanos/síntesis química , Ciclohexanos/farmacología , Ácidos Grasos Insaturados/síntesis química , Ácidos Grasos Insaturados/farmacología , Metaloendopeptidasas/metabolismo , Ratones , Pruebas de Sensibilidad Parasitaria , Sesquiterpenos/síntesis química , Sesquiterpenos/química , Sesquiterpenos/farmacología
8.
Cell ; 138(1): 63-77, 2009 Jul 10.
Artículo en Inglés | MEDLINE | ID: mdl-19596235

RESUMEN

Structure-specific endonucleases mediate cleavage of DNA structures formed during repair of collapsed replication forks and double-strand breaks (DSBs). Here, we identify BTBD12 as the human ortholog of the budding yeast DNA repair factor Slx4p and D. melanogaster MUS312. Human SLX4 forms a multiprotein complex with the ERCC4(XPF)-ERCC1, MUS81-EME1, and SLX1 endonucleases and also associates with MSH2/MSH3 mismatch repair complex, telomere binding complex TERF2(TRF2)-TERF2IP(RAP1), the protein kinase PLK1 and the uncharacterized protein C20orf94. Depletion of SLX4 causes sensitivity to mitomycin C and camptothecin and reduces the efficiency of DSB repair in vivo. SLX4 complexes cleave 3' flap, 5' flap, and replication fork structures; yet unlike other endonucleases associated with SLX4, the SLX1-SLX4 module promotes symmetrical cleavage of static and migrating Holliday junctions (HJs), identifying SLX1-SLX4 as a HJ resolvase. Thus, SLX4 assembles a modular toolkit for repair of specific types of DNA lesions and is critical for cellular responses to replication fork failure.


Asunto(s)
Reparación del ADN , Recombinasas/metabolismo , Animales , Línea Celular , Roturas del ADN de Doble Cadena , Daño del ADN , Replicación del ADN , Proteínas de Unión al ADN/metabolismo , Endonucleasas/metabolismo , Humanos , Complejos Multiproteicos/metabolismo , Recombinasas/química , Recombinasas/genética
9.
Nature ; 431(7007): 471-6, 2004 Sep 23.
Artículo en Inglés | MEDLINE | ID: mdl-15386015

RESUMEN

Recent studies on the control of specific metabolic pathways in bacteria have documented the existence of entirely RNA-based mechanisms for controlling gene expression. These mechanisms involve the modulation of translation, transcription termination or RNA self-cleavage through the direct interaction of specific intracellular metabolites and RNA sequences. Here we show that an analogous RNA-based gene regulation system can effectively be designed for mammalian cells via the incorporation of sequences encoding self-cleaving RNA motifs into the transcriptional unit of a gene or vector. When correctly positioned, the sequences lead to potent inhibition of gene or vector expression, owing to the spontaneous cleavage of the RNA transcript. Administration of either oligonucleotides complementary to regions of the self-cleaving motif or a specific small molecule results in the efficient induction of gene expression, owing to inhibition of self-cleavage of the messenger RNA. Efficient regulation of transgene expression is shown in a variety of mammalian cell lines and live animals. In conjunction with other emerging technologies, this methodology may be particularly applicable to the development of gene regulation systems tailored to any small inducer molecule, and provide a novel means of biological sensing in vivo that may have an important application in the regulated delivery of protein therapeutics.


Asunto(s)
Regulación de la Expresión Génica , Ingeniería Genética/métodos , ARN Catalítico/antagonistas & inhibidores , ARN Catalítico/metabolismo , Adenosina/farmacología , Animales , Emparejamiento Base , Secuencia de Bases , Catálisis/efectos de los fármacos , Línea Celular , Línea Celular Tumoral , Cricetinae , Regulación de la Expresión Génica/efectos de los fármacos , Genes Reporteros/genética , Vectores Genéticos/genética , Humanos , Ratones , Datos de Secuencia Molecular , Oligonucleótidos/química , Oligonucleótidos/genética , Oligonucleótidos/metabolismo , Oligonucleótidos/farmacología , Especificidad de Órganos , ARN Catalítico/química , ARN Catalítico/genética , ARN Mensajero/genética , ARN Mensajero/metabolismo , Toyocamicina/farmacología
10.
J Biol Chem ; 278(45): 44904-12, 2003 Nov 07.
Artículo en Inglés | MEDLINE | ID: mdl-12952957

RESUMEN

Crystal structures of the class II major histocompatibilty complex (MHC) protein, HLA-DR1, generally show a tight fit between MHC and bound peptide except in the P6/P7 region of the peptide-binding site. In this region, there is a shallow water-filled pocket underneath the peptide and between the pockets that accommodate the P6 and P7 side chains. We investigated the properties of this pocket with the idea of engineering substitutions into the corresponding region of peptide antigens to increase their binding affinity for HLA-DR1. We investigated d-amino acids and N-alkyl modifications at both the P6 and P7 positions of the peptide and found that binding of peptides to HLA-DR1 could be increased by incorporating an N-methyl substitution at position 7 of the peptide. The crystal structure of HLA-DR1 bound to a peptide containing a P7 N-methyl alanine was determined. The N-methyl group orients in the P6/P7 pocket, displacing one of the waters usually bound in this pocket. The structure shows that the substitution does not alter the conformation of the bound peptide, which adopts the usual polyproline type II helix. An antigenic peptide carrying the N-methyl modification is taken up by antigen-presenting cells and loaded onto endogenous class II MHC molecules for presentation, and the resultant MHC-peptide complexes activate antigen-specific T-cells. These results suggest a possible strategy for increasing the affinity of weakly immunogenic peptides that might be applicable to the development of vaccines and diagnostic reagents.


Asunto(s)
Alanina/análogos & derivados , Antígeno HLA-DR1/química , Péptidos/metabolismo , Alanina/análisis , Secuencia de Aminoácidos , Sitios de Unión , Cristalización , Antígeno HLA-DR1/genética , Antígeno HLA-DR1/metabolismo , Humanos , Enlace de Hidrógeno , Activación de Linfocitos , Metilación , Modelos Moleculares , Estructura Molecular , Péptidos/química , Péptidos/inmunología , Conformación Proteica , Estructura Secundaria de Proteína , Sarcosina/análisis , Relación Estructura-Actividad , Linfocitos T/inmunología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA